Implantable Systems and Microparticle Depots: Meeting the Formulation and Manufacturing Challenges of Long-Acting Drug Delivery
“Implantable Systems and Microparticle Depots: Meeting the Formulation and Manufacturing Challenges of Long-Acting Drug Delivery” Interested in learning how depot injections and implantable systems provide tunable delivery that addresses complex solubility, bioavailability, and stability issues? Register for this webinar for a deep dive into long-acting drug products, including guidance on dosage form selection, design choices, polymer options, and manufacturing techniques for depot injections and implantable systems. Learn how critical quality attributes such as in vitro drug release and particle size distribution are measured with real-world case studies. Live: Wednesday, Sept.11, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Sept. 11, 2020 Register free
Register free: http://www.pharmtech.com/pt_w/implants_depots
Event Overview:
A growing number of APIs suffer from poor water solubility, low bioavailability, and insufficient stability. As more BCS class II–IV compounds enter the drug development pipeline, formulators must look to advanced drug delivery systems to achieve a desired therapeutic effect and protect APIs from degradation.
Long-acting dosage forms such as microparticle depot injections and implantable systems-both biodegradable and biodurable-offer tunable designs that help overcome these challenges. However, successful development and optimization of these complex drug products requires specialized knowledge, equipment, and facilities to properly execute.
This webinar will explore key considerations in developing long-acting drug products, including a comparison of design options, polymers, and manufacturing methods for both depots and implants. Experts will investigate some of the common challenges in these areas and explain how long-acting dosage forms are characterized with real-world case studies.
Key Learning Objectives:
- Explore the growth of long-acting drug delivery with an emphasis on microparticle depot injections and implantable systems
- Review long-acting dosage form selection, design choices, polymer options, and manufacturing techniques
- Investigate common challenges and solutions for developing, manufacturing, and characterizing long-acting drug products-including a review of in vitro release testing and measuring particle size distribution
- Provide real-world case study data to demonstrate how long-acting drug products can be customized to achieve a specific therapeutic effect
Speakers: Dr. Andrew Loxley, International Formulation Development Consultant, Particle Sciences, a Lubrizol Life Science Company
Dr. Kimberly Zubris, Director of Drug Delivery Technologies, Particle Sciences, a Lubrizol Life Science Company
Time and date:Wednesday, Sept.11, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until Sept. 11, 2020
Sponsor: Particle Sciences, a Lubrizol Life Science Company
Register free: http://www.pharmtech.com/pt_w/implants_depots
